One hypothesis suggests that the differential response to ondansetron - and serotonin-specific re-uptake inhibitors ( SSRIs ) may be due to a functional polymorphism of the 5 ' - HTTLPR promoter region in SLC6A4 , the gene that codes for the serotonin transporter ( 5-HTT ) .